Analysis of the Fv1 alleles involved in the susceptibility of mice to lactate dehydrogenase-elevating virus-induced polioencephalomyelitis

Journal of NeuroVirology

Volumn 6, Issue 1, 2000, Pages 89-93

  Monteyne, Philippe ^a,b   Coulie, Pierre G ^a   Coutelier, Jean Paul ^a  

^a DE DUVE INSTITUTE   (Belgium)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Gene; Lactate dehydrogenase elevating virus; Polioencephalomyelitis; Retrovirus

Indexed keywords

ALLELE; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENCEPHALOMYELITIS; FEMALE; GENETIC SUSCEPTIBILITY; INFECTION SENSITIVITY; LACTIC DEHYDROGENASE TOGAVIRUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POINT MUTATION; POLIOMYELITIS; PRIORITY JOURNAL;

ANIMALIA; LACTATE DEHYDROGENASE-ELEVATING VIRUS; TOGAVIRIDAE; UNIDENTIFIED RETROVIRUS;

EID: 0034022529     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550280009006386     Document Type: Article

References (33)

1. Anderson GW, Even C, Rowland RRR, Palmer GA, Harty JT, Plagemann PGW (1995a). C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase-elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age. J Neurovirol 1: 244-252.
2. Anderson GW, Palmer GA, Rowland RRR, Even C, Plagemann PGW (1995b). Infection of central nervous system cells by ecotropic murine leukemia virus in C58 and AKR mice and in inutero-infected CE/J mice predisposes mice to paralytic infection by lactate dehydrogenase-elevating virus. J Virol 69: 308-319.
3. Bénit L, De Parseval N, Casella JF, Callebaut I, Cordonnier A, Heidmann T (1997). Cloning of a new murine endogenous retrovirus, MuERV-L, with strong similarity to the human HERV-L element and with a gag coding sequence closely related to the Fv1 restriction gene. J Virol 71: 5652-5657.
4. Bentley DM, Morris RE (1982). T cell subsets required for protection against age-dependent polioencephalomyelitis. J Immunol 128: 530-534.
5. Bentley DM, Watson SR, Morris RE (1983). Age-related loss of Lyt-1,2 cells in C58 mice results in susceptibility to lactic dehydrogenase virus-induced polioencephalomyelitis. Inf Immun 41: 1389-1390.
6. Best S, Le Tissier P, Towers G, Stoye JP (1996). Positional cloning of the mouse retrovirus restriction gene FV1. Nature (London) 382: 826-829.
7. Chen Z, Li K, Rowland RRR, Plagemann PGW (1999). Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice. J Neurovirol 5: 200-208.
8. Chen Z, Rowland RRR, Anderson GW, Palmer GA, Plagemann PGW (1997). Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection. J Virol 71: 2913-2920.
9. Coffin JM (1996). Retrovirus restriction revealed. Nature (London) 382: 762-763.
10. Contag CH, Plagemann PGW (1988). Susceptibility of C58 mice to paralytic disease induced by lactate dehydrogenase-elevating virus correlates with increased expression of endogenous retrovirus in motor neurons. Microb Pathog 5: 287-296.
11. Contag CH, Plagemann PGW (1989). Age-dependent poliomyelitis of mice: expression of endogenous retrovirus correlates with cytocidal replication of lactate dehydrogenase-elevating virus in motor neurons. J Virol 63: 4362-4369.
12. Duffey PS, Martinez D, Abrams GD, Murphy WH (1976). Pathogenic mechanisms in immune polioencephalomyelitis: induction of disease in immunosuppressed mice. J Immunol 116: 475-481.
13. Faaberg KS, Palmer GA, Even C, Anderson GW, Plagemann PGW (1995). Differential glycosylation of the ectodomain of the primary envelope glycoprotein of two strains of lactate dehydrogenase-elevating virus that differ in neuropathogenicity. Virus Res 39: 331-340.
14. Godeny EK, Chen L, Kumar SN, Methven SL, Koonin EV, Brinton MA (1993). Complete genomic sequence and phylogenetic analysis of the lactate dehydrogenase-elevating virus (LDV). Virology 194: 585-596.
15. Goff SP (1996). Minireview. Operating under a Gag order: a block against incoming virus by the Fv1 gene. Cell 86: 691-693.
16. Herr W, Gilbert W (1982). Germ-line MuLV reintegrations in AKR/J mice. Nature (London) 296: 865-868.
17. Inada T, Kikuchi H, Yamazaki S (1993). Comparison of the ability of lactate dehydrogenase-elevating virus and its virion RNA to infect murine leukemia virus-infected or -uninfected cell lines. J Virol 67: 5698-5703.
18. Jolicoeur P (1979). The Fv-1 gene of the mouse and its control of murine leukemia virus replication. Curr Top Microbiol Immunol 86: 67-122.
19. Jolicoeur P, Baltimore D (1976). Effect of Fv-1 gene product on proviral DNA formation and integration in cells infected with murine leukemia viruses. Proc Natl Acad Sci USA 73: 2236-2240.
20. Kozak CA (1985). Analysis of wild-derived mice for Fv-1 and Fv-2 murine leukemia virus restriction loci: a novel wild mouse Fv-1 allele responsible for lack of host range restriction. J Virol 55: 281-285.
21. Kozak CA, Chakraborti A (1996). Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance. Virology 225: 300-305.
22. Lilly F, Pincus T (1973). Genetic control of murine viral leukemogenesis. Adv Cancer Res 17: 231-277.
23. Martinez D, Brinton MA, Tachovsky TG, Phelps AH (1980). Identification of lactate dehydrogenase-elevating virus as the etiological agent of genetically restricted, age-dependent polioencephalomyelitis of mice. Infect Immun 27: 979-987.
24. Mayer A, Duran-Reynals ML, Lilly F (1978). Fv-1 regulation of lymphoma development and of thymic, ecotropic and xenotropic MuLV expression in mice of the AKR/J × RF/J cross. Cell 15: 429-435.
25. Monteyne P, Meite M, Coutelier JP (1997). Involvement of CD4+ cells in the protection of C58 mouse against polioencephalomyelitis induced by lactate dehydrogenase-elevating virus. J Neurovirol 3: 380-384.
26. Murphy WH, Nawrocki JF, Pease LR (1983). Age-dependent paralytic viral infection in C58 mice: possible implications in human neurologic disease. Prog Brain Res 59: 291-303.
27. Nawrocki JF, Pease LR, Murphy WH (1980). Etiologic role of lactic dehydrogenase virus infection in an age-dependent neuroparalytic disease in C58 mice. Virology 103: 259-264.
28. Odaka T (1969). Inheritance of susceptibility to Friend mouse leukemia virus. V. Introduction of a gene responsible for susceptibility in the genetic complement of resistant mice. J Virol 3: 543-548.
29. Pease LR, Abrams GD, Murphy WH (1982). FV-1 restriction of age-dependent paralytic lactic dehydrogenase virus infection. Virology 117: 29-37.
30. Pease LR, Murphy WH (1980). Co-infection by lactic dehydrogenase virus and C-type retrovirus elicits neurological disease. Nature (London) 286: 398-400.
31. Pincus T, Hartley JW, Rowe WP (1971). A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally occurring viruses. J Exp Med 133: 1219-1233.
32. Steeves R, Lilly F (1977). Interactions between host and viral genomes in mouse leukemia. Ann Rev Genet 11: 277-296.
33. Stroop WG, Brinton MA (1983). Mouse strain-specific central nervous system lesions associated with lactate dehydrogenase-elevating virus infection. Lab Invest 49: 334-345.